文献速递外周动脉疾病

血管内去神经术改善外周动脉疾病患者肢体缺血:一项随机临床试验

Endovascular Denervation for the Improvement of Limb Ischemia in Patients with Peripheral Artery Disease: A Randomized Clinical Trial.
PubMed 文献 · Ann Vasc Surg · 2023-12-16

一项单中心随机临床试验纳入38例外周动脉疾病患者,比较经皮血管介入(PVI)联合血管内去神经术(EDN)与单纯PVI的疗效。结果显示联合组6个月踝肱指数变化和经皮氧分压变化均优于单纯PVI组,3个月Rutherford分级改善率更高,术后1周疼痛评分下降更明显,两组均无器械或手术相关主要不良事件。

要点

  • PVI+EDN组6个月Δ踝肱指数0.44±0.31 vs 单纯PVI组0.24±0.15,P=0.018。
  • PVI+EDN组6个月Δ经皮氧分压15.68±16.72 vs 单纯PVI组4.95±13.43,P=0.036。
  • PVI+EDN组3个月Rutherford分级改善率100.00% vs 单纯PVI组68.42%,P=0.02。

核心结论

  • 在这项单中心、异质性队列的先导性分析中,与单纯PVI相比,PVI联合EDN在6个月时显示出肢体缺血的显著改善。

研究设计与样本

  • 从2019年8月至2021年4月,38例符合条件的外周动脉疾病患者被随机等分为两组:PVI组和PVI+EDN组,后者在PVI前于髂动脉和股动脉行EDN。
  • 主要终点为术后6个月踝肱指数的改善。
  • 次要终点为经皮氧分压、Rutherford分级、数字评分量表评分和安全性。

主要发现

  • PVI和EDN的技术成功率均为100%,两组均无器械相关或手术相关主要不良事件发生。
  • 与单纯PVI相比,PVI+EDN在6个月时显示出肢体血流动力学的显著改善(Δ踝肱指数0.44±0.31 vs 0.24±0.15,P=0.018)。
  • PVI+EDN组6个月时外周动脉疾病的微循环灌注显著更好(Δ经皮氧分压15.68±16.72 vs 4.95±13.43,P=0.036)。
  • 与PVI组相比,PVI+EDN组在3个月随访时Rutherford分级显著改善(100.00% vs 68.42%,P=0.02)。
  • 术后1周,PVI+EDN组数字评分量表评分的下降幅度大于PVI组(3[2-5] vs 4[4-6],P=0.022)。

关键数值与推荐

  • 6个月Δ踝肱指数:PVI+EDN组0.44±0.31 vs 单纯PVI组0.24±0.15,P=0.018。
  • 6个月Δ经皮氧分压:PVI+EDN组15.68±16.72 vs 单纯PVI组4.95±13.43,P=0.036。
  • 3个月Rutherford分级改善率:PVI+EDN组100.00% vs 单纯PVI组68.42%,P=0.02。
  • 术后1周数字评分量表评分:PVI+EDN组3[2-5] vs 单纯PVI组4[4-6],P=0.022。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述为单中心、异质性队列的先导性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate the safety and efficacy of endovascular denervation (EDN) as an adjunct to percutaneous vascular intervention (PVI) for peripheral artery disease (PAD). METHODS: From August 2019 to April 2021, 38 eligible patients with PAD enrolled in this study were randomly and equally assigned into 2 groups: the PVI group and the PVI + EDN group treated with EDN at the iliac and femoral arteries before PVI. The primary endpoint was the improvement in the ankle brachial index at 6 months after the procedure. The secondary endpoints were transcutaneous oxygen pressure (TcPO2), Rutherford category, numerical rating scale score, and safety. RESULTS: The technical success rates of PVI and EDN were 100%, and no device-related or procedure-related major adverse events occurred in either group. Compared with PVI alone, PVI + EDN demonstrated a significant improvement in limb hemodynamics at 6 months (Δ ankle brachial index 0.44 ± 0.31 vs. 0.24 ± 0.15, P = 0.018). Microcirculatory perfusion of PAD was significantly better at 6 months in the PVI + EDN group (ΔTcPO2, 15.68 ± 16.72 vs. 4.95 ± 13.43, P = 0.036). The Rutherford category was significantly improved in the PVI + EDN group in comparison with the PVI group at the 3-month follow-up (100.00% vs. 68.42%, P = 0.02). The decrease in the numerical rating scale score in the PVI + EDN group was greater than that in the PVI group at 1 week following the procedure (3 [2-5] vs. 4 [4-6], P = 0.022). CONCLUSIONS: In this single-center pilot analysis of a heterogeneous cohort of patients with PAD, PVI with EDN demonstrated a significant improvement in limb ischemia at 6 months compared with PVI alone.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zhao GF, Pan T, Yan R, et al. Endovascular Denervation for the Improvement of Limb Ischemia in Patients with Peripheral Artery Disease: A Randomized Clinical Trial. Ann Vasc Surg. 2023. PMID: 38104925. doi:10.1016/j.avsg.2023.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。